Neuromodulators: Multi-Domain Functions And Context Dependence

Issue 61 Edition 2026-03-02 6 min read

General

Sources: 1 • Confidence: Medium • Updated: 2026-03-02 19:40

Key takeaways

Epinephrine is the main neurotransmitter for the sympathetic nervous system.
When an action potential reaches a presynaptic axon terminal, neurotransmitters are released, cross the synapse, and bind postsynaptic receptors to produce a response.
The show is bringing back its Instagram presence and will post a summary of the neurotransmitters discussed.
In reinforcement learning of a motor skill, repetition strengthens synapses via glutamate-related changes, and positive feedback triggers dopamine release that increases available glutamate receptor sites to further strengthen the connection.
People with anxiety typically have higher serotonin levels than would be appropriate.

Epinephrine is the main neurotransmitter for the sympathetic nervous system.
Norepinephrine increases arousal and supports attention, mood expression, and decision making by optimizing neural firing under cognitive effort.
Dopamine is tied to reward and reinforcement, implicated in addiction, associated with motivation, and involved in motor control in basal ganglia circuits.
Serotonin is involved in depression treatment targets and plays roles in digestion, sleep, anxiety, mood, appetite, and social behavior.
Histamine supports wakefulness, and higher histamine levels aid staying awake; histamine also plays a role in inflammatory responses to injury.
Endorphins are released to produce feelings of happiness or euphoria.

When an action potential reaches a presynaptic axon terminal, neurotransmitters are released, cross the synapse, and bind postsynaptic receptors to produce a response.
Glutamate is the main excitatory neurotransmitter in the central nervous system.
Glutamate release at a synapse increases the likelihood that the postsynaptic neuron will fire, enabling association formation (e.g., linking face and name representations).
GABA is a primary inhibitory neurotransmitter in the brain, and glycine is a primary inhibitory neurotransmitter in the spinal cord.
Glutamate is the most abundant major neurotransmitter in the brain, followed by inhibitory neurotransmitters such as GABA and glycine.

The show is bringing back its Instagram presence and will post a summary of the neurotransmitters discussed.
The podcast intends to continue through 2025 and beyond.
New t-shirt and merchandise design ideas are in progress and are expected to be released.

In reinforcement learning of a motor skill, repetition strengthens synapses via glutamate-related changes, and positive feedback triggers dopamine release that increases available glutamate receptor sites to further strengthen the connection.

People with anxiety typically have higher serotonin levels than would be appropriate.

What operational definition of “serotonin levels” is intended in the anxiety claim (systemic vs regional signaling, baseline comparison, and measurement method)?
Do the Instagram return and neurotransmitter summary post actually occur, and if so, what is the posting cadence afterward?
Are the merch design ideas converted into actual product listings, and on what timeline?
Does the podcast continue releasing episodes through 2025 and beyond as stated?
What boundary conditions are assumed for the described dopamine–glutamate reinforcement mechanism (task type, brain circuits, and what counts as “positive feedback”)?

Podcast content emphasizes neurotransmitters, learning, and anxiety biology, suggesting potential audience demand for neuroscience education and mental health adjacent content, which could support monetization via distribution channels if operational follow through occurs.
Stated plans to return to Instagram with summaries and to launch merch imply an intent to expand top of funnel engagement and diversify revenue beyond audio, contingent on actual execution and sustained cadence.
The explicit and possibly contentious serotonin anxiety claim introduces reputational and platform risk if interpreted as clinical guidance, potentially affecting distribution, partnerships, and brand trust.

Instagram account resumes activity and posts the promised neurotransmitter summary, followed by a consistent posting cadence over subsequent weeks.
Merch design ideas become actual product listings with public availability and continued promotion across channels.
Podcast continues publishing new episodes through 2025 and beyond with stable release frequency, indicating operational continuity.

No Instagram return or summary post materializes, or activity stops shortly after, undermining stated distribution expansion.
Merch does not progress from ideas to listings within a reasonable window, or launches once without follow up, weakening monetization expectations.
Backlash, corrections, or platform actions tied to the serotonin anxiety claim reduce distribution reach or force content changes, signaling elevated brand risk.